Tibet Rhodiola Pharmaceutical Holding Future Growth
Future criteria checks 5/6
Tibet Rhodiola Pharmaceutical Holding is forecast to grow earnings and revenue by 25.7% and 20.5% per annum respectively. EPS is expected to grow by 25.6% per annum. Return on equity is forecast to be 29.9% in 3 years.
Key information
25.7%
Earnings growth rate
25.6%
EPS growth rate
| Healthcare earnings growth | 23.0% |
| Revenue growth rate | 20.5% |
| Future return on equity | 29.9% |
| Analyst coverage | Low |
| Last updated | 19 Aug 2024 |
Recent future growth updates
No updates
Recent updates
At CN¥33.30, Is Tibet Rhodiola Pharmaceutical Holding Co. (SHSE:600211) Worth Looking At Closely?
Sep 25
Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) Could Easily Take On More Debt
Sep 02Insufficient Growth At Tibet Rhodiola Pharmaceutical Holding Co. (SHSE:600211) Hampers Share Price
Jul 29Investors Shouldn't Overlook Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Impressive Returns On Capital
Jul 12Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) Seems To Use Debt Rather Sparingly
May 21Shareholders Will Be Pleased With The Quality of Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Earnings
May 03Under The Bonnet, Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Returns Look Impressive
Mar 22Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 4,828 | 1,464 | N/A | 1,373 | 1 |
| 12/31/2025 | 4,070 | 1,215 | N/A | 1,188 | 1 |
| 12/31/2024 | 3,438 | 1,025 | N/A | 908 | 1 |
| 9/30/2024 | 2,942 | 737 | 1,011 | 1,027 | N/A |
| 6/30/2024 | 2,929 | 828 | 1,095 | 1,113 | N/A |
| 3/31/2024 | 2,932 | 811 | 1,098 | 1,116 | N/A |
| 12/31/2023 | 3,134 | 801 | 1,042 | 1,063 | N/A |
| 9/30/2023 | 2,964 | 782 | 968 | 1,020 | N/A |
| 6/30/2023 | 3,032 | 703 | 861 | 907 | N/A |
| 3/31/2023 | 2,805 | 498 | 922 | 979 | N/A |
| 12/31/2022 | 2,555 | 370 | 735 | 837 | N/A |
| 9/30/2022 | 2,535 | 233 | 531 | 534 | N/A |
| 6/30/2022 | 2,444 | 173 | 416 | 476 | N/A |
| 3/31/2022 | 2,300 | 226 | 86 | 389 | N/A |
| 12/31/2021 | 2,139 | 209 | -59 | 367 | N/A |
| 9/30/2021 | 1,945 | 512 | 41 | 551 | N/A |
| 6/30/2021 | 1,782 | 496 | -3 | 607 | N/A |
| 3/31/2021 | 1,571 | 447 | 117 | 510 | N/A |
| 12/31/2020 | 1,373 | 418 | 207 | 428 | N/A |
| 9/30/2020 | 1,314 | 398 | 205 | 410 | N/A |
| 6/30/2020 | 1,266 | 375 | 244 | 308 | N/A |
| 3/31/2020 | 1,256 | 370 | 449 | 490 | N/A |
| 12/31/2019 | 1,256 | 312 | 441 | 490 | N/A |
| 9/30/2019 | 1,218 | 224 | 328 | 389 | N/A |
| 6/30/2019 | 1,194 | 243 | 488 | 539 | N/A |
| 3/31/2019 | 1,112 | 218 | 337 | 370 | N/A |
| 12/31/2018 | 1,028 | 216 | 266 | 289 | N/A |
| 9/30/2018 | 1,014 | 326 | 334 | 327 | N/A |
| 6/30/2018 | 933 | 301 | N/A | 215 | N/A |
| 3/31/2018 | 883 | 244 | N/A | 157 | N/A |
| 12/31/2017 | 916 | 230 | N/A | 91 | N/A |
| 9/30/2017 | 947 | 215 | N/A | 251 | N/A |
| 6/30/2017 | 980 | 195 | N/A | 210 | N/A |
| 3/31/2017 | 946 | 232 | N/A | 219 | N/A |
| 12/31/2016 | 797 | 198 | N/A | 250 | N/A |
| 9/30/2016 | 665 | 145 | N/A | 104 | N/A |
| 6/30/2016 | 720 | 129 | N/A | 158 | N/A |
| 3/31/2016 | 1,013 | 103 | N/A | 190 | N/A |
| 12/31/2015 | 1,383 | 92 | N/A | 134 | N/A |
| 9/30/2015 | 1,678 | 54 | N/A | 87 | N/A |
| 6/30/2015 | 1,820 | 25 | N/A | 27 | N/A |
| 3/31/2015 | 1,762 | 21 | N/A | -47 | N/A |
| 12/31/2014 | 1,668 | 21 | N/A | -141 | N/A |
| 9/30/2014 | 1,647 | 44 | N/A | 91 | N/A |
| 6/30/2014 | 1,547 | 38 | N/A | 112 | N/A |
| 3/31/2014 | 1,465 | 32 | N/A | 186 | N/A |
| 12/31/2013 | 1,402 | 27 | N/A | 279 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 600211's forecast earnings growth (25.7% per year) is above the savings rate (2.8%).
Earnings vs Market: 600211's earnings (25.7% per year) are forecast to grow slower than the CN market (26.1% per year).
High Growth Earnings: 600211's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 600211's revenue (20.5% per year) is forecast to grow faster than the CN market (13.9% per year).
High Growth Revenue: 600211's revenue (20.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 600211's Return on Equity is forecast to be high in 3 years time (29.9%)